RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

The RAPS store will be under maintenance Saturday, 6 June between 6 AM and 12 PM EST. Store functionality may be unavailable at times during this window.
We apologize for any inconvenience caused during this time.

Regulatory Focus™ > News Articles > Good Laboratory Practice for Nonclinical Laboratory Studies: A Review

Good Laboratory Practice for Nonclinical Laboratory Studies: A Review

Posted 01 July 2008 | By

The US Food and Drug Administration promulgated the Good Laboratory Practice regulations for nonclinical laboratory studies in 1979, following the discovery that data in studies submitted in support of an application had been falsified. GLPs are intended to ensure the quality and integrity of safety data, allow experiments to be reconstructed accurately and support the approval of new products. They are codified in 21 CFR Part 58, which is broken down into subparts A through K, with subparts H and I reserved. Each subpart provides a description and clarification of the regulation being reviewed.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe